Drugmakers, health groups bring poor girls vaccine

[riky]

Drugmakers, health groups bring poor girls vaccine

<p><a href="http://news.yahoo.com/drugmakers-health-groups-bring-poor-girls-vaccine-112248163.html"><img src="http://l2.yimg.com/bt/api/res/1.2/NZWeW460ms3Hfl2OPgB.OA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3B4b2ZmPTUwO3B5b2ZmPTA7cT04NTt3PTEzMA--/http://media.zenfs.com/en_us/News/ap_webfeeds/1c62125094bd5c0f310f6a706700c0ba.jpg" width="130" height="86" alt="FILE - In this Friday, Feb. 2, 2007 file photo, one dose of the vaccine Gardasil, developed by Merck &amp; Co., is displayed in Austin, Texas. On Thursday, May 9, 2013, the GAVI Alliance, a public-private partnership that's worked with drugmakers to deliver affordable vaccines to poor countries to treat childhood illnesses, announced a program that will team multinational drugmakers Merck &amp; Co. and GlaxoSmithKline with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. Merck &amp; Co. and GlaxoSmithKline PLC initially will provide 2.4 million doses of their vaccines against cancer-causing human papilloma virus, for a fraction of the cost commanded in Western countries. Merck will supply its Gardasil for $4.50 per dose, and Glaxo its Cervarix for $4.60 per dose. In the U.S., the shots cost well over $100 apiece, and a three-dose series over six months is required.(AP Photo/Harry Cabluck, File)" align="left" title="FILE - In this Friday, Feb. 2, 2007 file photo, one dose of the vaccine Gardasil, developed by Merck &amp; Co., is displayed in Austin, Texas. On Thursday, May 9, 2013, the GAVI Alliance, a public-private partnership that's worked with drugmakers to deliver affordable vaccines to poor countries to treat childhood illnesses, announced a program that will team multinational drugmakers Merck &amp; Co. and GlaxoSmithKline with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. Merck &amp; Co. and GlaxoSmithKline PLC initially will provide 2.4 million doses of their vaccines against cancer-causing human papilloma virus, for a fraction of the cost commanded in Western countries. Merck will supply its Gardasil for $4.50 per dose, and Glaxo its Cervarix for $4.60 per dose. In the U.S., the shots cost well over $100 apiece, and a three-dose series over six months is required.(AP Photo/Harry Cabluck, File)" border="0" /></a>TRENTON, N.J. (AP) â€" Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login